Skip to content
RDL Network logo
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer — G. Stathopoulos (2003) | RDL Network